ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,329, issued on Feb. 4, was assigned to Keygene N.V. (Wageningen, Netherlands).
"Methods of targeted genetic alteration in plant cells" was invented by Paul Bundock (Wageningen, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The current invention relates to methods of targeted genetic alteration in cells, preferably plant cells, as well as to plant cells and plants thus obtained using at least a fusion protein comprising a site-specific nuclease domain and a deaminase domain, or a construct encoding the same. The method also provides for a composition and a kit comprising a combination of a first fusion protein comprising a cytosine deamin...